Mutation-positive and mutation-negative patients with Cowden and Bannayan-Riley-Ruvalcaba syndromes associated with distinct 10q haplotypes

American Journal of Human Genetics

Volumn 79, Issue 5, 2006, Pages 923-934

  Pezzolesi, Marcus G ^a   Li, Yan ^b   Zhou, Xiao Ping ^a,c   Pilarski, Robert ^b,c   Shen, Lei ^b   Eng, Charis ^a,d  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TUMOR SUPPRESSOR PROTEIN;

ALLELE; ARTICLE; BANNAYAN RILEY RUVALCABA SYNDROME; CHROMOSOME 10; CLINICAL FEATURE; CONTROLLED STUDY; COWDEN SYNDROME; FAMILIAL CANCER; GENE; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MULTIPLE CANCER; PATHOGENESIS; PENETRANCE; PHENOTYPE; PRIORITY JOURNAL; PROTEUS LIKE SYNDROME; PTEN GENE; PTEN HAMARTOMA TUMOR SYNDROME;

EID: 33751078321     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/508943     Document Type: Article

References (33)

1. Eng C (2003) PTEN: one gene, many syndromes. Hum Mutat 22:183-198
2. Maehama T, Dixon JE (1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273:13375-13378
3. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95:29-39
4. Marsh DJ, Kum JB, Lunetta KL, Bennett MJ, Gorlin RJ, Ahmed SF, Bodurtha J, et al (1999) PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet 8:1461-1472
5. Eng C (2000) Will the real Cowden syndrome please stand up: revised diagnostic criteria. J Med Genet 37:828-830
6. Pilarski R, Eng C (2004) Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet 41:323-326
7. Zhou XP, Waite KA, Pilarski R, Hampel H, Fernandez MJ, Bos C, Dasouki M, Feldman GL, Greenberg LA, Ivanovich J, Matloff E, Patterson A, Pierpont ME, Russo D, Nassif NT, Eng C (2003) Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. Am J Hum Genet 73:404-411
8. Smith JM, Kirk EP, Theodosopoulos G, Marshall GM, Walker J, Rogers M, Field M, Brereton JJ, Marsh DJ (2002) Germline mutation of the tumour suppressor PTLN in Proteus syndrome. J Med Genet 39:937-940
9. Zhou X, Hampel H, Thiele H, Gorlin RJ, Hennekam RC, Parisi M, Winter KM, Eng G (2001) Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes. Lancet 358:210-211
10. Loffeld A, McLellan NJ, Cole T, Payne SJ, Fricker D, Moss G (2006) Epidermal naevus in Proteus syndrome showing loss of heterozygosity for an inherited PTEN mutation. Br J Dermatol 154:1194-1198
11. Bonneau D, Longy M (2000) Mutations of the human PTEN gene. Hum Mutat 16:109-122
12. Nelen MR, Padberg GW, Peeters EA, Lin AY, van den Helm B, Frants RR, Coulon V, Goldstein AM, van Reen MM, Easton DL, Eeles RA, Hodgsen S, Mulvihill JJ, Murday VA, Tucker MA, Mariman EC, Starink TM, Ponder BA, Ropers HH, Kremer H, Longy M, Eng G (1996) Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet 13:114-116
13. Carethers JM, Furnari LB, Zigman AF, Lavine JL, Jones MC, Graham GE, Teebi AS, Huang HJ, Ha HT, Chauhan DP, Chang CL, Cavenee WK, Boland CR (1998) Absence of PTEN/MMAC1 germ-line mutations in sporadic Bannayan-Riley-Ruvalcaba syndrome. Cancer Res 58:2724-2726
14. 1 method. Methods 25:402-408
15. Abecasis GR, Cookson WO (2000) GOLD-graphical overview of linkage disequilibrium. Bioinformatics 16:182-183
16. Zhang K, Deng M, Chen T, Waterman MS, Sun F (2002) A dynamic programming algorithm for haplotype block partitioning. Proc Natl Acad Sci USA 99:7335-7339
17. Gabriel SH, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward K, Lander ES, Daly MJ, Altshuler D (2002) The structure of haplotype blocks in the human genome. Science 296:2225-2229
18. Clayton D, Chapman J, Cooper J (2004) Use of unphased multilocus genotype data in indirect association studies. Genet Epidemiol 27:415-428
19. Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989
20. Cochran W (1954) Some methods of strengthening the common chi-square tests. Biometrics 10:417-451
21. 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA 97:10483-10488
22. Greenwood TA, Kelsoe JR (2003) Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene. Genomics 82:511-520
23. Yu C, Zhou Y, Miao X, Xiong P, Tan W, Lin D (2004) Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer. Cancer Res 64:7622-7628
24. Kleinjan DA, van Heyningen V (2005) Long-range control of gene expression: emerging mechanisms and disruption in disease. Am J Hum Genet 76:8-32
25. Haiman CA, Stram DO, Cheng I, Giorgi EE, Pooler L, Penney K, Le Marchand L, Henderson BE, Freedman MI. (2006) Common genetic variation at PTEN and risk of sporadic breast and prostate cancer. Cancer tpidemiol Biomarkers Prev 15:1021-1025
26. Hamilton JA, Stewart LM, Ajayi L, Gray IC, Gray NE, Roberts KG, Watson GJ, Kaisary AV, Snary D (2000) The expression profile for the tumour suppressor gene PTRN and associated polymorphic markers. Br J Cancer 82:1671-1676
27. Zhang L, Kendler KS, Chen X (2006) Association of the phosphatase and tensin homolog gene (PTEN) with smoking initiation and nicotine dependence. Am J Med Genet B Neuropsychiatr Genet 141:10-14
28. Excoffier L, Slatkin M (1995) Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12:921-927
29. Lewontin KC (1964) The interaction of selection and linkage. 11. Optimum models. Genetics 50:757-782
30. Bonnen PE, Wang PJ, Kimmel M, Chakraborty R, Nelson DL (2002) Haplotype and linkage disequilibrium architecture for human cancer-associated genes. Genome Res 12:1846-1853
31. Niu T, Qin ZS, Xu X, Liu JS (2002) Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms. Am J Hum Genet 70:157-169
32. Tishkoff SA, Pakstis AJ, Ruano G, Kidd KK (2000) The accuracy of statistical methods for estimation of haplotype frequencies: an example from the CD4 locus. Am J Hum Genet 67:518-522
33. Stephens M, Donnelly P (2003) A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162-1169